Abstract
Despite enormous research in the field of hypertension, its pathophysiology still remains largely unresolved and appears to be multifactorial. In the present communication, we have analyzed the status of nitric oxide (NO) in the patients with essential hypertension and age matched controls. We have found that the levels of NO are lowered in essential hypertension. The normalization of blood pressure by administration of antihypertensive therapy causes rise in the NO level indicating that perturbed NO status in essential hypertension is reversible. Addition of antioxidant to the antihypertensive drugs causes a further, though non significant, rise in the levels of NO, suggesting that antioxidants may be combined with antihypertensive drugs as adjunct in the management of essential hypertension.
Key words: Nitric oxide, Essential hypertension, Antihypertensive treatment, Antioxidants
Full Text
The Full Text of this article is available as a PDF (279.9 KB).
References
- 1.Anggard E. Nitric oxide: mediator, murderer and medicine. Lancet. 1994;343:1199–1206. doi: 10.1016/S0140-6736(94)92405-8. [DOI] [PubMed] [Google Scholar]
- 2.Tschudi M.R., Mesaros S., Luscher T.F., et al. Directin situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. Hypertension. 1996;27:32–35. doi: 10.1161/01.hyp.27.1.32. [DOI] [PubMed] [Google Scholar]
- 3.Panza J.A., Quyyumi A.A., Brush J.E. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N. Eng. J. Med. 1990;323:22–27. doi: 10.1056/NEJM199007053230105. [DOI] [PubMed] [Google Scholar]
- 4.Linder L., Kiowski W., Buhler F.R., et al. Indirect evidence for release of endothelium derived relaxing factor in human forearm circulationin vitro. Circulation. 1990;81:1762–1767. doi: 10.1161/01.cir.81.6.1762. [DOI] [PubMed] [Google Scholar]
- 5.Forte P., Copland M., Smith L.M., et al. Basal nitric oxide synthesis in essential hypertension. Lancet. 1997;349:837–842. doi: 10.1016/S0140-6736(96)07631-3. [DOI] [PubMed] [Google Scholar]
- 6.Taddei S., Virdis A., Ghiadoni L., et al. Cyclo-oxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension. 1997;27:32–35. doi: 10.1161/01.hyp.29.1.274. [DOI] [PubMed] [Google Scholar]
- 7.Privat C., Lanotoine F., Bedioni F., et al. Nitric oxide production; comparison of three methods of quantification. Life Sci. 1997;61:1193–1202. doi: 10.1016/S0024-3205(97)00661-9. [DOI] [PubMed] [Google Scholar]
- 8.Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in relaxation of arterial smooth muscle by acetyl choline. Nature. 1980;288:373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
- 9.Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature. 1987;327:524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
- 10.Lowenstein C.J., Dinerman J.L., Snyder S.H. Nitric oxide: a physiological messenger. Ann. Intern. Med. 1994;120:227–237. doi: 10.7326/0003-4819-120-3-199402010-00009. [DOI] [PubMed] [Google Scholar]
- 11.Iiyama K., Nagano M., Yo Y., et al. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am. Heart J. 1996;132:779–782. doi: 10.1016/S0002-8703(96)90311-7. [DOI] [PubMed] [Google Scholar]
- 12.Huang P.L., Huang J., Mashimo H., et al. Hypertension in mice lacking gene for nitric oxide synthase. Nature. 1995;132:239–242. doi: 10.1038/377239a0. [DOI] [PubMed] [Google Scholar]
- 13.Cuevas P., Ala-Calvo M., Carceller F., et al. Correction of hypertension by normalization of endothelial levels of spontaneously hypertensive rats. Proc. Nat. Acad. Sci. USA. 1996;93:11996–12001. doi: 10.1073/pnas.93.21.11996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Anderson T.J., Meredith I.T., Ganz P., et al. Nitric oxide and nitrohypertensives: similarities differences and potential interactions. J. Am. Coll. Cardiol. 1994;24:5550–5560. doi: 10.1016/0735-1097(94)90316-6. [DOI] [PubMed] [Google Scholar]
- 15.Panza J.A., Quyyumi A.A., Callahan T.S., et al. Effect of antihypertensive treatment on endothelium dependent vascular relaxation in patients with essential hypertension. J. Am. Coll. Cardiol. 1993;21:1145–1151. doi: 10.1016/0735-1097(93)90238-V. [DOI] [PubMed] [Google Scholar]
- 16.Kumar K.V., Das U. Are free radicals involved in pathophysiology of human essential hypertension? Free Radical Res. Commun. 1993;19:59–66. doi: 10.3109/10715769309056499. [DOI] [PubMed] [Google Scholar]
- 17.Galley H.F., Thornton J., Nowdle P.D., et al. Combination of oral antioxidant supplementation reduces blood pressure. Clin. Sci. 1997;92:361–365. doi: 10.1042/cs0920361. [DOI] [PubMed] [Google Scholar]
- 18.Bonnardaux A., Nadaud S., Charru A., et al. Lack of evidence for linkage of endothelial cell nitric oxide gene to essential hypertension. Circulation. 1995;91:96–102. doi: 10.1161/01.cir.91.1.96. [DOI] [PubMed] [Google Scholar]
- 19.Yamada S.S., Sassaki A.L., Fujihara C.K., et al. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade. Hypertension. 1996;27:1165–1172. doi: 10.1161/01.hyp.27.5.1165. [DOI] [PubMed] [Google Scholar]
- 20.Ruilope L.M., Lahera V., Rodicio J.L., et al. Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J. Hypertens. 1994;12:625–631. [PubMed] [Google Scholar]